The DOI matches its Crossref record; 106 of the 107 references it cites were found in a registry or an index.
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
Open accessAbstract
BACKGROUND AND AIMS: Vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic resonance elastography (MRE), and magnetic resonance imaging (MRI) have been proposed as non-invasive tests for patients with non-alcoholic fatty liver disease (NAFLD). This study evaluated their diagnostic accuracy for liver fibrosis and non-alcoholic steatohepatitis (NASH). METHODS: PubMED/MEDLINE, EMBASE and the Cochrane Library were searched for studies examining the diagnostic accuracy of these index tests, against histology as the reference standard, in adult patients with NAFLD. Two authors independently screened and assessed methodological quality of studies and extracted data. Summary estimates of sensitivity, specificity and area under the curve (sAUC) were calculated for fibrosis stages and NASH, using a random effects bivariate logit-normal model. RESULTS: We included 82 studies (14,609 patients). Meta-analysis for diagnosing fibrosis stages was possible in 53 VCTE, 11 MRE, 12 pSWE and 4 2DSWE studies, and for diagnosing NASH in 4 MRE studies. sAUC for diagnosis of significant fibrosis were: 0.83 for VCTE, 0.91 for MRE, 0.86 for pSWE and 0.75 for 2DSWE. sAUC for diagnosis of advanced fibrosis were: 0.85 for VCTE, 0.92 for MRE, 0.89 for pSWE and 0.72 for 2DSWE. sAUC for diagnosis of cirrhosis were: 0.89 for VCTE, 0.90 for MRE, 0.90 for pSWE and 0.88 for 2DSWE. MRE had sAUC of 0.83 for diagnosis of NASH. Three (4%) studies reported intention-to-diagnose analyses and 15 (18%) studies reported diagnostic accuracy against pre-specified cut-offs. CONCLUSIONS: When elastography index tests are acquired successfully, they have acceptable diagnostic accuracy for advanced fibrosis and cirrhosis. The potential clinical impact of these index tests cannot be assessed fully as intention-to-diagnose analyses and validation of pre-specified thresholds are lacking. LAY SUMMARY: Non-invasive tests that measure liver stiffness or use magnetic resonance imaging (MRI) have been suggested as alternatives to liver biopsy for assessing the severity of liver scarring (fibrosis) and fatty inflammation (steatohepatitis) in patients with non-alcoholic fatty liver disease (NAFLD). In this study, we summarise the results of previously published studies on how accurately these non-invasive tests can diagnose liver fibrosis and inflammation, using liver biopsy as the reference. We found that some techniques that measure liver stiffness had a good performance for the diagnosis of severe liver scarring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several substantial comparative studies have shown that MRE provides at least equal quality in fi brosis staging as ultrasound-based elastography techniques.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Self-citationDesign and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Self-citationProgression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Castera, L., Friedrich-Rust, M., & Loomba, R. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.036 · Cited by 1,494
Eddowes, P. J., Sasso, M., Allison, M., Tsochatzis, E. A., Anstee, Q. M., Sheridan, D. A., Guha, I. N., Cobbold, J., Deeks, J. J., Paradis, V., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.042 · Cited by 1,425
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322
Flagged first, then by citations
1 of the 107 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Al Juboori, 2018, The utility of liver elastography in evaluation of liver fibrosis in obese patients undergoing bariatric surgery, Hepatology, 68
- Clet, 2018, Expanding the Use of the VCTE XL probe in morbid obese patients: validation of a new automated adaptive measurement depths algorithm in a large UK multicenter cohort, Hepatology, 68
- Hee, 2014, Comparison of NAFLD Fibrosis Score (NFS) and transient elastography (Fibroscan), alone and in combination, as non-invasive methods for the evaluation of fibrosis in non-alcoholic fatty liver disease (NAFLD), J Gastroenterol Hepatol, 29, 76
- Pais, 2011, Validation of a simple algorithm combining serum markers and elastometry for the diagnosis of fibrosis in NAFLD, Hepatology, 54
Cited by
Sorted by citations
Items 301–375 of 375
Non-Invasive Examination toDiagnose Non-Alcoholic Fatty LiverDisease (NAFLD): An Update
周, 娟. (2023) · Nursing Science · doi:10.12677/ns.2023.126148
Goncharov, A. А., Нисановна, С. А., & Va, I. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-222-2-55-63
Clinical diagnosis and evaluation pathway
Lam, R., Banini, B. A., Do, A., & Lim, J. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99649-5.00003-0
Noninvasive evaluation of liver fibrosis in MASLD—Imaging/elastography based
Zhang, X., Li, G., Lin, H., Wong, V. W., & Wong, G. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99649-5.00005-4
Shen, J., Fan, Z., Ren, L., Cheng, Y., & Wu, C.-W. G. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4894782
Lin, Y.-H., Wu, Y.-F., Wang, P., Chen, M., Tu, Y.-C., Hsieh, Y., & Lin, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4706149/v1
米田, 正. (2024) · JAPANES JOURNAL OF MEDICAL INSTRUMENTATION · doi:10.4286/jjmi.94.354
Stratégie diagnostique des hépatopathies chroniques
Canivet, C. M. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-78562-7.00006-0
Zhu, N., Li, Y., Lin, Y., Cui, X., & Li, X. (2024) · Research Square · doi:10.21203/rs.3.rs-5308727/v1
Detection of hepatic steatosis with ultrasound attenuation imaging compared to MRIPreprint
Alvaro Postigliatti, F., Aris, R., Constenla, D., Campos, O., Faúndes, G. S., Cea, J., González, F., Cavada, G., Ginesta, A., & Silva, C. (2024) · Research Square · doi:10.21203/rs.3.rs-5341525/v1
Puhakka, E., Ahmed, H., Haikonen, R., Leclercq, S., Hanhineva, K., Maccioni, L., Amadieu, C., Lehtonen, M., Männistö, V., Rysä, J., et al. (2024) · medRxiv · doi:10.1101/2024.12.10.24318756
Tang, X., Wang, F., Gao, Y., Liu, Y., Zhao, S.-L., Lu, J. L., Qin, J., & Zhang, B. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5061164
Vidal‐Cevallos, P., Chávez-Tapia, N. C., & Tsochatzis, E. A. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_5
Histopathology of MASLD: Insights into Liver Tissue Changes
Francque, S., & Driessen, A. L. C. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_6
Magnetic Resonance Imaging Quantification of Steatosis, Iron, and Fibrosis in Chronic Liver Disease
Aguado, D. M., & Martí‐Bonmatí, L. (2025) · Neuromethods · doi:10.1007/978-1-0716-4354-9_3
Kamada, Y., Sumida, Y., Takahashi, H., Fujii, H., Kawanaka, M., Nakajima, A., & Forum, J. (2025) · Kanzo · doi:10.2957/kanzo.66.105
Gou, X., & Cheng, J. (2024) · Radiology of Infectious Diseases · doi:10.4103/rid.rid-d-24-00010
Marcos, P. J. T., López‐González, Á. A., Rifá, E. M.-A., Paublini, H., Sánchez, C. M., López, P. J. T., & Ramírez‐Manent, J. I. (2025) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2025.102514
Liang, J., Shi, F., Zhang, L., Yin, S., & Chen, Y. (2025) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/0115734056379123250626163120
Introductory Chapter: Elastography in Gastrointestinal and Liver Disease
Roy, A., Goenka, U., & Goenka, M. K. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010939
Colli, A., Casazza, G., & Fraquelli, M. (2025) · Hepatology · doi:10.1097/hep.0000000000001470
Migacz, M., Pluta, D., Barański, K., Kujszczyk, A., Kochanowicz, M., & Holecki, M. T. (2025) · Biomedicines · doi:10.3390/biomedicines13081878
Stroes, A.-S. R., Benninga, M. A., & Koot, B. G. P. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.08.006
Attention-driven graph-based machine learning for non-invasive diagnosis of NAFLD
Srivastava, E., Mohan, S., Gandhi, T. K., Choudhury, A. K., & Kumar, S. (2025) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2025.100288
Chen, Z., Zhu, X., Guo, J., & Ma, G. (2025) · International Journal of Endocrinology · doi:10.1155/ije/4478977
Nichtinvasive Marker zur Bestimmung der Fibrose und Zirrhose
Jhaisha, S. A., & Trautwein, C. (2025) · Springer eBooks · doi:10.1007/978-3-662-70167-6_6
Liang, Y., Hu, N., Xia, X., Li, F., Yang, M., Lei, P., & Luo, P. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09437-6
Demidova, T. Y., Titova, V. V., Levitskaya, A. N., & Gyozalyan, M. A. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-456
Perspective Chapter: Multiparametric Ultrasound in the Evaluation of Fatty Liver Disease
Sporea, I., Popa, A., & Popescu, A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005896
Zhu, K., Bedi, H. K., Chahal, D., Kim, J. P., Yoshida, E. M., & Kwan, P. (2025) · Canadian Liver Journal · doi:10.3138/canlivj-2024-0049
Hassankhani, A., Valizadeh, P., Jannatdoust, P., Amoukhteh, M., Mohammadi, A., Gholamrezanezhad, A., & Haq, A. (2025) · medRxiv · doi:10.64898/2025.12.11.25342122 · Cited by 1
Associations of lipoprotein subclasses with risk of cardiovascular disease in individuals with MASLD
Chen, S., Zhang, J., Yu, H., Xiong, S., Zhao, Y., Bai, S., Jiang, J., Pan, A., & Cheng, B. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104530
Feng, Y., Zheng, S., Liu, L., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23550268
Zhang, M., Wang, Y., Liu, M., Shi, Q., Wu, X., & Zhou, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1692394
Ichikawa, S. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70225
Imaging-Based Modalities for Identifying At Risk MASH. A Diagnostic Test Meta-Analysis
Gunalan, S. Z., Law, M. S. N., Kua, Y. X., Yu, Z., Lim, R. Y., Selvakumar, A., Syn, N. L. X., Wijarnpreecha, K., Nah, B. K. Y., Zhang, Z. X., et al. (2026) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003919
Singhai, A., Meena, R., Joshi, R. P., Khadanga, S., & Jhaj, R. (2026) · Cureus · doi:10.7759/cureus.101710
Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Kalligeros, M., Castéra, L., Tsochatzis, E. A., & Alkhouri, N. (2026) · Clinics in Liver Disease · doi:10.1016/j.cld.2025.12.004
Noritake, H., Inoue, T., Yonekura, T., Tamakoshi, H., Ida, Y., Matsumoto, M., Hanaoka, T., Yamashita, M., Umemura, M., Ohta, K., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.02.012
Liu, Y., Wang, B., Wang, L., Xiong, H., Zhang, H., & Cheng, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1740126
Zeng, C., Zhou, S., Luo, H., Zhong, S., Yang, P., Yin, W., Zhou, Z., & Yang, Y. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.117763
Kositamongkol, C., Tantiyavarong, P., Ratanatawan, A., Sripongpun, P., Mahawithitwong, P., Kositamongkol, P., Saokaew, S., & Phisalprapa, P. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344985
Wassenaar, N. P. M., van Son, K. C., Voermans, B., van Eekhout, K. M. A., Troelstra, M., Driessen, S., Mak, A. L., Witjes, J. J., van Dijk, A., Houttu, V., et al. (2026) · European Radiology · doi:10.1007/s00330-026-12451-5
Su, Y., Dodge, J. L., & Lee, B. P. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.03.004
Tokimori, T., Saitoh, S., Ohira, S., Suzuki, H., Kurita, I., Tano, M., & Kozuka, T. (2026) · Abdominal Radiology · doi:10.1007/s00261-026-05490-5
周, 晓. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641733
Najafova, V. N. (2026) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2026.01.046
Diabetic kidney disease: Radiological assessment and clinical correlations
Silipigni, S., Gembillo, G., Cicero, L. L., Ferrara, S. A., Ricca, M. F., Spadaro, G., Soraci, L., & Bottari, A. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i5.118278
Reduction in Hepatic Phosphatidylcholine Biosynthesis Promotes MASH Through Copper DeficiencyPreprint
Welles, J. E., Garifallou, J. P., Gonzalez, M. V., Santoleri, D., Choudhury, F. K., DeNicola, G. M., Martin, R. W., Jiang, C., Kim, J., Li, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.13.723926
Roy, A., Jajodia, S., Chakraborty, S., Keyal, S., Tewari, A., Sonthalia, N., Chakrabarti, S., Roy, S., Khandelwal, R., Ghoshal, U. C., et al. (2026) · Abdominal Radiology · doi:10.1007/s00261-026-05565-3
Application and interpretation of non-invasive testing in MetALD
Chan, W., Liu, K., Goh, G. B., & Wong, V. W. (2026) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2026.30
Moya‐Salazar, J., Liviapoma-Rojas, G. S., Aliaga-Refulio, C., Goicochea‐Palomino, E. A., Moya-Salazar, M. J., Morales-Martinez, M. E., & Espinoza‐Morriberón, D. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23060701
Wu, Y.-T., Shi, Y.-L., Xie, X., Ma, J., Dang, Y.-Q., & Hu, D. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.117869
Alhujaily, M. M., Tayeb, F. J., Felemban, M. F., & Shafie, A. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-026-05762-2
Lu, Z., He, C., Wang, M., He, W., Wang, S., Xie, Y., & Pan, X. (2026) · International Journal of Endocrinology · doi:10.1155/ije/3395722
Mo, S., Ding, Z., Huang, Z., Wang, M., Xu, J., Zhang, H., & Dong, F. (2026) · Advanced ultrasound in diagnosis and therapy · doi:10.26599/audt.2026.250108
Imaging-based fibrosis assessment and risk stratification in MASLD
Jin, S., Zhou, T., Jin, D., Xie, J., Sheng, G., Li, H., Li, G., Qin, C., & Gao, P. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1880238
Meharwade, S., Gupta, S., Goyal, A., Kandasamy, D., Shalimar, Gamanagatti, S., Das, P., Mehndiratta, A., Kalaivani, M., & Sharma, R. (2026) · Abdominal Radiology · doi:10.1007/s00261-026-05676-x
Romeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Puorto, L. D., Indipendente, M., Gregorio, A. D., Dallio, M., & Federico, A. (2026) · Livers · doi:10.3390/livers6040071
Sommese, P., Boccia, F., Mugione, P., Rosa, I. D., Guerriero, L., Tolone, S., Cafarella, I., Bertolino, L., Cuccurullo, D., Docimo, L., et al. (2026) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003211
Wang, X. W., Dong, X., 钱洛丹, Yang, Z., Yang, D., & Niu, Y. (2026) · Academic Radiology · doi:10.1016/j.acra.2026.06.068
The Use of Ultrasound-Based Elastography Techniques in Liver Fibrosis: A Narrative Review
Silva, A. P. D., Hathurusinghe, S., Niriella, M. A., & Silva, H. J. D. (2026) · Diagnostics · doi:10.3390/diagnostics16172694
MRI in MASLD: technical foundations and guideline-based applications
Pu, J., Zhu, L., Wu, Y., Ping, F., Xu, J., Zhou, K., Wang, X., & Pan, J. (2026) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2026-002471 · Cited by 1
Leveraging serum CHI3L1 and machine learning for non-invasive liver fibrosis diagnostics
Chen, H., Zhang, G., Zhang, Y., Li, L., Che, Y., & Huang, J. (2026) · iScience · doi:10.1016/j.isci.2026.117372
Noninvasive surrogate endpoints in MASH trials: current perspectives and challenges
Lee, H. W., Díaz, L. A., Wong, V. W., & Chan, W. (2026) · Hepatology International · doi:10.1007/s12072-026-11148-7
Kratzer, W., Binzberger, A., Kauschke, S. G., Dolze, F., Werner, M., Barth, T. F. E., Feller, M., Neubauer, H., Simon, E., Brunner, A., et al. (2026) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/a-2942-6555
Beyond FIB-4–VCTE agreement: an imaging-triggered pathway for fibrosis screening in MASLD
Xu, T., & Yang, T. (2026) · Annals of Hepatology · doi:10.1016/j.aohep.2026.102452
EASL-EASD-EASO guidance on the use of resmetirom and semaglutide as MASH-targeted therapy
Tacke, F., Horn, P., Wong, V. W. S., Ratziu, V., Bugianesi, E., Francque, S., Zelber‐Sagi, S., Caussy, C., Roden, M., Gastaldelli, A., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.08.028
Mignot, V., Baron, A., Decaens, T., & Costentin, C. E. (2026) · Liver International · doi:10.1111/liv.70923
Wang, L., Ding, L., Ji, G., 高玉杰, Zhang, J., Zhu, C., Wang, W., & Xu, M. (2026) · Research Square · doi:10.21203/rs.3.rs-11193667/v1
Metabolic Dysfunction‐Associated Steatotic Liver Disease
Kanwal, F., & Wong, V. W. S. (2026) · Wiley eBooks · doi:10.1002/9781394360031.ch31
Groß, F. J., Flé, G., Chaudry, O., Nguyen, T.-T., Abbas, I., Bickelhaupt, S., Mathy, S., Arnold, C., Bäuerle, T. D., Fautz, H., et al. (2026) · medRxiv · doi:10.64898/2026.10.23.26358292
Wang, C., Zhang, J., Tian, X., Teng, X., Gong, L., Shi, J., & 袁震鸣 (2026) · Bioengineering · doi:10.3390/bioengineering13111281
Metadata
- Authors
- Selvaraj, E. A., Mózes, F. E., Jayaswal, A. N. A., Zafarmand, M. H., Vali, Y., Lee, J. A., Levick, C. K., Young, L. A. J., Palaniyappan, N., Liu, C.-H., Aithal, G. P., Romero-Gómez, M., Brosnan, M. J., Tuthill, T. A., Anstee, Q. M., Neubauer, S., Harrison, S. A., Bossuyt, P. M., Pavlides, M., Anstee, Q., Daly, A., Johnson, K., Govaere, O., Cockell, S., Tiniakos, D., Bedossa, P., Oakley, F., Cordell, H., Day, C., Wonders, K., Bossuyt, P., Zafarmand, H., Vali, Y., Lee, J., Ratziu, V., Clement, K., Pais, R., Schuppan, D., Schattenberg, J., Vidal-Puig, T., Vacca, M., Rodrigues-Cuenca, S., Allison, M., Kamzolas, I., Petsalaki, E., Oresic, M., Hyötyläinen, T., McGlinchey, A., Mato, J. M., Millet, O., Dufour, J.-F., Berzigotti, A., Pavlides, M., Harrison, S., Neubauer, S., Cobbold, J., Mozes, F., Akhtar, S., Banerjee, R., Kelly, M., Shumbayawonda, E., Dennis, A., Erpicum, C., Romero-Gómez, M., Gómez-González, E., Ampuero, J., Castell, J., Gallego-Durán, R., Fernández, I., Montero-Vallejo, R., Karsdal, M., Erhardtsen, E., Rasmussen, D., Leeming, D. J., Fisker, M. J., Sinisi, A., Musa, K., Betsou, F., Sandt, E., Tonini, M., Bugianesi, E., Rosso, C., Armandi, A., Marra, F., Gastaldelli, A., Svegliati, G., Boursier, J., Francque, S., Vonghia, L., Ekstedt, M., Kechagias, S., Yki-Jarvinen, H., Luukkonen, P., van Mil, S., Papatheodoridis, G., Cortez-Pinto, H., Valenti, L., Petta, S., Miele, L., Geier, A., Trautwein, C., Aithal, G., Hockings, P., Newsome, P., Wenn, D., Pereira Rodrigues, C. M., Chaumat, P., Hanf, R., Trylesinski, A., Ortiz, P., Duffin, K., Brosnan, J., Tuthill, T., McLeod, E., Ertle, J., Younes, R., Ostroff, R., Alexander, L., Kjær, M. S., Mikkelsen, L. F., Balp, M.-M., Brass, C., Jennings, L., Martic, M., Loeffler, J., Hanauer, G., Shankar, S., Fournier, C., Pepin, K., Ehman, R., Myers, J., Ho, G., Torstenson, R., Myers, R., & Doward, L.
- Affiliations
- University of Oxford (GB)
- Nottingham University Hospitals NHS Trust (GB)
- Pfizer (United States) (US)
- Amsterdam University Medical Centers (NL)
- Instituto de Biomedicina de Sevilla (ES)
- ORCID
- Selvaraj, Emmanuel Anandraj
- Jayaswal, Arjun Narayan Ajmer
- Lee, Jenny A.
- Levick, Christina Kim
- Young, Liam Arnold Joseph
- Palaniyappan, Naaventhan
- Liu, Chang-Hai
- Aithal, Guruprasad Padur
- Tuthill, Theresa A.
- Anstee, Quentin M.
- Daly, Ann
- Johnson, Katherine
- Govaere, Olivier
- Cockell, Simon
- Tiniakos, Dina
- Oakley, Fiona
- Cordell, Heather
- Day, Chris
- Wonders, Kristy
- Ratziu, Vlad
- Pais, Raluca
- Schuppan, Detlef
- Schattenberg, Jörn
- Kamzolas, Ioannis
- Petsalaki, Evangelia
- Hyötyläinen, Tuulia
- Dufour, Jean-François
- Berzigotti, Annalisa
- Cobbold, Jeremy
- Banerjee, Rajarshi
- Kelly, Matt
- Shumbayawonda, Elizabeth
- Dennis, Andrea
- Gómez-González, Emilio
- Ampuero, Javier
- Karsdal, Morten
- Rasmussen, Daniel
- Betsou, Fay
- Bugianesi, Elisabetta
- Rosso, Chiara
- Armandi, Angelo
- Marra, Fabio
- Gastaldelli, Amalia
- Boursier, Jérôme
- Francque, Sven
- Vonghia, Luisa
- Ekstedt, Mattias
- Kechagias, Stergios
- Luukkonen, Panu
- Papatheodoridis, George
- Valenti, Luca
- Petta, Salvatore
- Miele, Luca
- Geier, Andreas
- Trautwein, Christian
- Hockings, Paul
- Newsome, Philip
- Ortiz, Pablo
- Duffin, Kevin
- Ertle, Judith
- Younes, Ramy
- Ostroff, Rachel
- Alexander, Leigh
- Kjær, Mette Skalshøi
- Mikkelsen, Lars Friis
- Balp, Maria-Magdalena
- Jennings, Lori
- Loeffler, Juergen
- Shankar, Sudha
- Fournier, Céline
- Pepin, Kay
- Ehman, Richard
- Ho, Gideon
- Doward, Lynda
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 75
- Issue
- 4
- Pages
- 770-785
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3161701468
- Cited by
- 376
- References
- 107
- Citations by year
- 2026: 67 · 2025: 84 · 2024: 77 · 2023: 81 · 2022: 52 · 2021: 14
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Deposito de Investigacion Universidad de Sevilla (University of Seville) (publishedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc-nd)
- Repository@Nottingham (University of Nottingham) (acceptedVersion, other-oa)
- Florence Research (University of Florence) (submittedVersion, cc-by-nc-nd)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by-nc-nd)
- Lirias (KU Leuven) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc-nd)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by-nc-nd)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, cc-by-nc-nd)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc-nd)
- Funders
- European Federation of Pharmaceutical Industries and Associations
- Innovative Medicines Initiative (777377)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Ultrasound Imaging and Elastography
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- non-alcoholic fatty liver disease, liver fibrosis, nonalcoholic steatohepatitis, vibration-controlled transient elastography, point shear wave elastography, two-dimensional shear wave elastography, magnetic resonance elastography, magnetic resonance imaging, noninvasive fibrosis assessment, liver cirrhosis, diagnostic accuracy
- MeSH terms
- Adult, Humans, Magnetic Resonance Imaging, ROC Curve, Area Under Curve, Elasticity Imaging Techniques, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
